Trial Profile

Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of Multiple Ascending Doses of CG400549 in Healthy Volunteers

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 13 May 2013

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Nilofabicin (Primary)
Indications Methicillin-resistant Staphylococcus aureus infections; Vancomycin-resistant Staphylococcus aureus infections
Focus Adverse reactions

Most Recent Events

13 May 2013 New source identified and integrated: ClinicalTrials.gov record.
11 May 2011 Status changed from planning to completed, according to information in a CrystalGenomics media release.
10 May 2010 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com